Active Comparator: Timolol 0.5%

DRUG2 trials

Sponsors

Allergan

Conditions

Glaucoma, Open-AngleOcular Hypertension

Phase 3

Efficacy and Safety Study of Bimatoprost Sustained-Release (SR) in Participants With Open-angle Glaucoma or Ocular Hypertension

CompletedNCT02247804

AllerganGlaucoma, Open-Angle, Ocular Hypertension

Start: 2014-12-15End: 2019-07-19Updated: 2020-06-11

Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-Angle Glaucoma or Ocular Hypertension

CompletedNCT02250651

AllerganGlaucoma, Open-Angle, Ocular Hypertension

Start: 2014-12-15End: 2020-07-22Updated: 2021-07-28

Related Papers

Bimatoprost Implant Biodegradation in the Phase 3, Randomized, 20-Month ARTEMIS Studies

Journal of Ocular Pharmacology and Therapeutics2022-11-1526 citations

Single Administration of Intracameral Bimatoprost Implant 10 µg in Patients with Open-Angle Glaucoma or Ocular Hypertension

Ophthalmology and Therapy2022-05-2827 citations

Phase 3, Randomized, 20-Month Study of the Efficacy and Safety of Bimatoprost Implant in Patients with Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 2)

Drugs2021-11-0162 citations

24-Month Phase I/II Clinical Trial of Bimatoprost Sustained-Release Implant (Bimatoprost SR) in Glaucoma Patients

Drugs2019-12-2896 citations